This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Vanderbilt University. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Curtis Thorne: Innovator in Cancer Treatment
Introduction
Curtis Thorne is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of monoclonal antibodies.
Latest Patents
Thorne holds 1 patent for his invention titled "Methods of using an antibody to inhibit WNT-mediated signaling in cancer." This patent focuses on monoclonal antibodies and fragments directed to LRP5/6, which are utilized in the prevention and treatment of cardiac remodeling and cancer. The invention also includes methods for employing these monoclonal antibodies in combating such diseases.
Career Highlights
Curtis Thorne is affiliated with Vanderbilt University, where he continues to advance his research in the medical field. His work has the potential to impact the lives of many individuals suffering from cancer and related conditions.
Collaborations
Thorne collaborates with esteemed colleagues, including Ethan Lee and Pampee P Young, to further enhance the scope and effectiveness of his research.
Conclusion
Curtis Thorne's innovative work in developing monoclonal antibodies represents a significant advancement in cancer treatment. His contributions are paving the way for new therapeutic approaches that could improve patient outcomes.